What’s In Store For Diagnostic & Pharma Stocks

#Thyrocare's Rahul Guha talks about the surge in diagnostic stocks and what's next for the #pharma sector. #bqlive 
---------------------------------------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/1318...
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

What's In Store For Diagnostic & Pharma Stocks? | BQ Prime

Pharmaceutical company Strides Pharma Science shares rose over 11.5% to hit a 52-week high; Details

Strides Pharma Shares Hit 52-Week High As USFDA Tentative Nod To HIV Treatment Drug - News18

Ajanta Pharma “outperformed” the market, led by ophthalmology therapy, pain therapy, and dermatology, the brokerage said.

Ajanta Pharma Shares At All-Time High After August Sales Data

Sale of existing drugs and new launches will drive 3-4 per cent volume growth.

Indian Pharma Industry To Log In 8-10% Revenue Growth This Fiscal: Crisil - News18

The Nifty Pharma index closed 0.58 per cent down at 15193.15.

Stock market update: Nifty Pharma index falls 0.58%

“Whenever we have seen a change of management like this, it has worked positively for shareholders. Look at what happened in JB Chemicals, and even then UniChem. All the acquisitions which have taken place in the pharma industry have been very positive for both the acquirer as well as the acquired c…

4+1 stocks that Dipan Mehta would keep in his 5-year-plus basket

Torrent Pharma shows interest in Cipla; PE players keen on buying promoter stake. If successful, it would change dynamics of domestic pharma industry. Torrent has pulled off several domestic acquisitions, incl. Elder Pharma & Unichem. Last year, bought Curatio Healthcare for Rs ₹2000 crore. Reports …

Deal street abuzz on Torrent Pharma’s possible interest in Cipla promoter stake

The Nifty Pharma index closed 0.2 per cent down at 15302.6.

Stock market update: Nifty Pharma index falls 0.2%

​The momentum had definitely weakened out there, we did see some consolidation happening out there but there was no price correction as like that of Nifty and Bank Nifty.

4 stocks Jay Thakkar is bullish on from pharma sector

The tablet will used for the treatment of children living with HIV weighing 6 kg to 25 kg and aged at least three months.

Aurobindo Pharma shares surge on plans to launch HIV tablet

Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.